3-氯-6-(1H-吡咯-1-基)哒嗪 | 5096-76-4

• 物质功能分类: 医药中间体 - 杂环化合物 - 哒嗪类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 3-氯-6-(1H-吡咯-1-基)哒嗪
• 中文别名: 3-氯-6-吡咯-1-基-吡啶；3-氯-6-(1-吡咯)哒嗪
• 英文名称: 3-chloro-6-pyrrol-1-ylpyridazine
• 英文别名: 3-chloro-6-(1H-pyrrol-1-yl)pyridazine；6-Chlor-3-pyrrolo-pyridazin；3-Chloro-6-pyrrol-1-yl-pyridazine
• CAS: 5096-76-4
• 化学式: C₈H₆ClN₃
• mdl: MFCD00828665
• 分子量: 179.609
• InChiKey: LQIVORYEWIDSDK-UHFFFAOYSA-N

物化性质

• 稳定性/保质期：
  在常温常压下保持稳定

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  30.7
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2933990090
• 储存条件：
  请将药品存放在避光、阴凉干燥的地方，并密封保存。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Chloro-6-(1H-pyrrol-1-yl)pyridazine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Chloro-6-(1H-pyrrol-1-yl)pyridazine
CAS number: 5096-76-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H6ClN3
Molecular weight: 179.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氯-6-(1H-吡咯-1-基)哒嗪 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 、 正丁醇 为溶剂， 生成 1-(2-Phenoxyethylamino)-3-(6-pyrrol-1-ylpyridazin-3-yl)oxypropan-2-ol
  参考文献：
  名称：

  Synthesis and hypotensive activity of novel 3-pyridazinyloxypropanolamines

  摘要：

  DOI：

  10.1016/0223-5234(91)90125-7
• 作为产物：
  描述：

  3,6-二氯哒嗪 、 吡咯 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 0.08h， 以83%的产率得到3-氯-6-(1H-吡咯-1-基)哒嗪
  参考文献：
  名称：

  An Electrochemical Nickel-Catalyzed Arylation of 3-Amino-6-Chloropyridazines

  摘要：

  3-Amino-6-aryl- and 3-amino-6-heteroarylpyridazines have been obtained in generally good yield using a nickel-catalyzed electrochemical cross-coupling between 3-amino-6-chloropyridazines and aryl or heteroaryl halides at room temperature. Comparative experiments involving classical palladium-catalyzed reactions, such as Suzuki, Stille, or Negishi cross-couplings, reveal that the electrochemical method can constitute a reliable alternative tool for biaryl formation. A possible reaction mechanism is proposed on the basis of electrochemical analyses.

  DOI：

  10.1021/jo3022428

文献信息

• Synthesis and biological evaluation of 3-amino-, 3-alkoxy- and 3-aryloxy-6-(hetero)arylpyridazines as potent antitumor agents
  作者：Stéphane Sengmany、Mathilde Sitter、Eric Léonel、Erwan Le Gall、Gervaise Loirand、Thierry Martens、Didier Dubreuil、Florian Dilasser、Morgane Rousselle、Vincent Sauzeau、Jacques Lebreton、Muriel Pipelier、Rémy Le Guével

  DOI：10.1016/j.bmcl.2018.12.050

  日期：2019.3

  Various 3-amino-, 3-aryloxy- and alkoxy-6-arylpyridazines have been synthesized by an electrochemical reductive cross-coupling between 3-amino-, 3-aryloxy- or 3-alkoxy-6-chloropyridazines and aryl or heteroaryl halides. In vitro antiproliferative activity of these products was evaluated against a representative panel of cancer cell lines (HuH7, CaCo-2, MDA-MB-231, HCT116, PC3, NCI-H727, HaCaT) and

  通过3-氨基-，3-芳氧基-或3-烷氧基-6-氯哒嗪与芳基或杂芳基卤化物之间的电化学还原交叉偶联，已经合成了各种3-氨基-，3-芳氧基-和烷氧基-6-芳基哒嗪。评估了这些产品对代表性癌细胞系（HuH7，CaCo-2，MDA-MB-231，HCT116，PC3，NCI-H727，HaCaT）的体外抗增殖活性，并强调了更有效衍生物的致癌性预防在建立人类乳腺癌细胞系MDA-MB 468-Luc与p44 / 42和Akt依赖性信号传导途径的相互作用之前，已对MDA-MB 468-Luc进行了研究。
• Synthesis and antihypertensive activity of new 6-heteroaryl-3-hydrazinopyridazine derivatives
  作者：Gerd Steiner、Josef Gries、Dieter Lenke

  DOI：10.1021/jm00133a013

  日期：1981.1

  examined on normotensive and spontaneously hypertensive rats by comparison with dihydralazine (I). 6-Imidazol-1-yl derivatives have proved particularly active. Of these derivatives, 3-hydrazino-6-(2-methylimidazol-1-yl)pyridazine (7c) achieves 4.9 times the activity of dihydralazine when administered orally to spontaneously hypertensive rats. The LD50 values of 7c and dihydralazine are very similar.

  描述了具有抗高血压作用的新型6-杂芳基-3-肼基哒嗪的合成和药理活性。通过三种不同的合成方法将吡咯，吡唑，咪唑，三唑，四唑，噻吩，吲哚和咔唑杂环引入到哒嗪核的6位。通过与二肼苯哒嗪（I）进行比较，对降压和自发性高血压大鼠的降压作用进行了检查。已证明6-咪唑-1-基衍生物具有特别的活性。在这些衍生物中，当对自发性高血压大鼠口服时，3-肼基-6-（2-甲基咪唑-1-基）哒嗪（7c）的活性是二肼苯哒嗪的4.9倍。7c和二肼苯哒嗪的LD50值非常相似。
• Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 Inhibitors
  作者：Gang Liu、John K. Lynch、Jennifer Freeman、Bo Liu、Zhili Xin、Hongyu Zhao、Michael D. Serby、Philip R. Kym、Tom S. Suhar、Harriet T. Smith、Ning Cao、Ruojing Yang、Rich S. Janis、Joel A. Krauser、Steven P. Cepa、David W. A. Beno、Hing L. Sham、Christine A. Collins、Teresa K. Surowy、Heidi S. Camp

  DOI：10.1021/jm070219p

  日期：2007.6.1

  Stearoyl-CoA desaturase 1 (SCD1) catalyzes the committed step in the biosynthesis of monounsaturated fatty acids from saturated, long-chain fatty acids. Studies with SCD1 knockout mice have established that these animals are lean and protected from leptin deficiency-induced and diet-induced obesity, with greater whole body insulin sensitivity than wild-type animals. In this work, we have discovered a series of potent, selective, orally bioavailable SCD1 inhibitors based on a known pyridazine carboxamide template. The representative lead inhibitor 28c also demonstrates excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells.
• Selective mono-amination of dichlorodiazines
  作者：Stéphane Sengmany、Julie Lebre、Erwan Le Gall、Eric Léonel

  DOI：10.1016/j.tet.2015.05.056

  日期：2015.7

  A mild, easy-to-perform, and versatile method for the formation of aminochlorodiazines from reaction of several types of dichlorodiazines (i.e., pyridazines, pyrimidines, and pyrazines) with primary or secondary amines in ethanol in the presence of triethylamine as a base, is described. The methodology is general and efficient despite noticeable difference in reactivity between diazines. While dichloropyridazine and dichloropyrazine require several hours of heating at reflux for the reaction to proceed, dichloropyrimidines reach completion within minutes at room temperature. (C) 2015 Elsevier Ltd. All rights reserved.
• STEINER G.; GRIES J.; LENKE D., J. MED. CHEM., 1981, 24, NO 1, 59-63
  作者：STEINER G.、 GRIES J.、 LENKE D.

  DOI：——

  日期：——